Literature DB >> 6099707

The use of cyclophosphamide in the treatment of multiple sclerosis.

H L Weiner, S L Hauser, D A Hafler, R J Fallis, J R Lehrich, D M Dawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6099707     DOI： 10.1111/j.1749-6632.1984.tb14808.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Neurology: immunotherapy in multiple sclerosis.

Authors:  J C Sipe
Journal:  West J Med       Date:  1987-03

2.  The need for a new strategy for the treatment of multiple sclerosis.

Authors:  A N Davison
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

3.  Cyclophosphamide has Long-Term Effects on Proliferation in Olfactory Epithelia.

Authors:  Nora Awadallah; Kara Proctor; Kyle B Joseph; Eugene R Delay; Rona J Delay
Journal:  Chem Senses       Date:  2020-03-25       Impact factor: 3.160

4.  Cyclophosphamide in relapsing remitting multiple sclerosis.

Authors:  F D'Andrea; C D'Aurizio; C Marini; M Prencipe
Journal:  Ital J Neurol Sci       Date:  1990-06

5.  T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

Authors:  A Henneberg; E G Fischer; H H Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.